NCT04207931Phase 4Recruiting
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 4
- Sponsor
- Wake Forest University Health Sciences
- Participants (registry)
- 250
- Start
- April 2018
- Primary completion
- November 2026 (planned)
- Study completion
- March 2027 (planned)
- Last registry update
- March 2026
- Countries
- United States
Conditions studied: Central Centrifugal Cicatricial Alopecia (CCCA)
Interventions: Topical steroid class I-II, Clobetasol, Betamethasone Dipropionate, or Fluocinonide, Triamcinolone Acetonide, Kenaolog, Doxycyline, Doxy-100, Targadox, Oracea, Minoxidil, Rogaine
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.